Mark Tarr - Encompass Health President, Chief Executive Officer, Director
| EHC Stock | USD 82.80 0.34 0.41% |
CEO
Mr. Mark J. Tarr is a President, Chief Executive Officer of the HealthSouth Corporationration Previously, he served as executive vice president of our operations since October 1, 2007, to which the chief operating officer designation was added on February 24, 2011. Mr. Tarr joined us in 1993 and has held various management positions with us, including serving as president of our inpatient division from 2004 to 2007, as senior vice president with responsibility for all inpatient operations in Texas, Louisiana, Arkansas, Oklahoma, and Kansas from 1997 to 2004, as director of operations of our 80bed rehabilitation hospital in Nashville, Tennessee from 1994 to 1997, and as chief executive officeradministrator of our 70bed rehabilitation hospital in Vero Beach, Florida from 1992 to 1994. since 2016.
| Age | 62 |
| Tenure | 8 years |
| Address | 9001 Liberty Parkway, Birmingham, AL, United States, 35242 |
| Phone | 205 967 7116 |
| Web | https://www.encompasshealth.com |
Mark Tarr Latest Insider Activity
Tracking and analyzing the buying and selling activities of Mark Tarr against Encompass Health stock is an integral part of due diligence when investing in Encompass Health. Mark Tarr insider activity provides valuable insight into whether Encompass Health is net buyers or sellers over its current business cycle. Note, Encompass Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Encompass Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Mark Tarr over a month ago Payment of 2487 shares by Mark Tarr of Encompass Health subject to Rule 16b-3 | ||
Mark Tarr over three months ago Payment of 25159 shares by Mark Tarr of Encompass Health subject to Rule 16b-3 | ||
Mark Tarr over six months ago Payment of 2895 shares by Mark Tarr of Encompass Health subject to Rule 16b-3 | ||
Mark Tarr over a year ago Acquisition by Mark Tarr of 49498 shares of Encompass Health subject to Rule 16b-3 |
Encompass Health Management Efficiency
The company has Return on Asset of 0.0779 % which means that on every $100 spent on assets, it made $0.0779 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.2284 %, implying that it generated $0.2284 on every 100 dollars invested. Encompass Health's management efficiency ratios could be used to measure how well Encompass Health manages its routine affairs as well as how well it operates its assets and liabilities. The current year's Return On Equity is expected to grow to 0.22, whereas Return On Tangible Assets are forecasted to decline to 0.05. At present, Encompass Health's Deferred Long Term Asset Charges is projected to decrease significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.46, whereas Total Assets are forecasted to decline to about 3.8 B.Similar Executives
| Found 1 records | CEO Age | ||
| Theodore CPA | Healthcare Services Group | 50 | |
Management Performance
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0779 |
Encompass Health Corp Leadership Team
Elected by the shareholders, the Encompass Health's board of directors comprises two types of representatives: Encompass Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Encompass. The board's role is to monitor Encompass Health's management team and ensure that shareholders' interests are well served. Encompass Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Encompass Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Christopher Reidy, Independent Director | ||
| John Darby, General VP | ||
| Jerry Gray, President Region | ||
| John Chidsey, Independent Director | ||
| Nancy Schlichting, Independent Director | ||
| Yvonne Curl, Independent Director | ||
| Leo Higdon, Non-Executive Independent Chairman of the Board | ||
| Andrew Price, Chief Accounting Officer | ||
| Mark Tarr, President, Chief Executive Officer, Director | ||
| Gregory Carmichael, Independent Director | ||
| Anthony Hernandez, Chief Human Resource Officer | ||
| Kevin Connor, Independent Director | ||
| Dawn Rock, Chief Officer | ||
| Linda Wilder, President Region | ||
| Elissa Charbonneau, Chief Medical Officer | ||
| Edmund Fay, Senior Vice President Treasurer | ||
| Joan Herman, Independent Director | ||
| Patricia Maryland, Independent Director | ||
| Charles Elson, Independent Director | ||
| L Shaw, Independent Director | ||
| Melanie Lewis, Senior Vice President Chief Business Development Officer | ||
| Peter Mantegazza, President Region | ||
| MS DO, Chief Officer | ||
| Mark Miller, Senior Vice President of Investor Relations | ||
| Terrance Williams, Independent Director | ||
| April Anthony, Chief Executive Officer and President - Encompass | ||
| Cheryl Levy, Chief Human Resource Officer | ||
| Patrick Darby, Executive Vice President General Counsel, Secretary | ||
| Barbara Jacobsmeyer, Executive Vice President and President - Inpatient Hospitals | ||
| Frank Brown, President Region | ||
| Leslye Katz, Independent Director | ||
| Rusty Yeager, Chief VP | ||
| Donald Correll, Independent Director | ||
| John Maupin, Independent Director | ||
| Douglas Coltharp, Chief Financial Officer, Executive Vice President | ||
| Kim Sullivan, Chief Human Resource Officer | ||
| Edward Shaw, Independent Director |
Encompass Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Encompass Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0779 | ||||
| Profit Margin | 0.07 % | ||||
| Operating Margin | 0.15 % | ||||
| Current Valuation | 11.56 B | ||||
| Shares Outstanding | 100.14 M | ||||
| Shares Owned By Insiders | 1.42 % | ||||
| Shares Owned By Institutions | 98.58 % | ||||
| Number Of Shares Shorted | 2.47 M | ||||
| Price To Earning | 18.73 X |
Pair Trading with Encompass Health
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Encompass Health position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Encompass Health will appreciate offsetting losses from the drop in the long position's value.Moving against Encompass Stock
| 0.8 | MCD | McDonalds Earnings Call This Week | PairCorr |
| 0.62 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
| 0.47 | CSCO | Cisco Systems Aggressive Push | PairCorr |
| 0.42 | PFE | Pfizer Inc Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to Encompass Health could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Encompass Health when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Encompass Health - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Encompass Health Corp to buy it.
The correlation of Encompass Health is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Encompass Health moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Encompass Health Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Encompass Health can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Encompass Health Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate. Note that the Encompass Health Corp information on this page should be used as a complementary analysis to other Encompass Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Complementary Tools for Encompass Stock analysis
When running Encompass Health's price analysis, check to measure Encompass Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Encompass Health is operating at the current time. Most of Encompass Health's value examination focuses on studying past and present price action to predict the probability of Encompass Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Encompass Health's price. Additionally, you may evaluate how the addition of Encompass Health to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |
Is Encompass Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Encompass Health. If investors know Encompass will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Encompass Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.03) | Dividend Share 0.6 | Earnings Share 3.59 | Revenue Per Share 48.253 | Quarterly Revenue Growth 0.096 |
The market value of Encompass Health Corp is measured differently than its book value, which is the value of Encompass that is recorded on the company's balance sheet. Investors also form their own opinion of Encompass Health's value that differs from its market value or its book value, called intrinsic value, which is Encompass Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Encompass Health's market value can be influenced by many factors that don't directly affect Encompass Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Encompass Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Encompass Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Encompass Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.